ATOSSA THERAPEUTICS, INC. Other Nonoperating Income (Expense)
ATOSSA THERAPEUTICS, INC. (ATOS) reported Other Nonoperating Income (Expense) of -$24.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-07
- ATOSSA THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2026-06-30 was -$24.00K.
- ATOSSA THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2026-03-31 was -$28.00K.
- ATOSSA THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2025-12-31 was $57.00K.
- ATOSSA THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was -$11.00K.
- ATOSSA THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2025 was -$6.00K.
- ATOSSA THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2024 was -$223.00K.
- ATOSSA THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2023 was -$70.00K.
- ATOSSA THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2022 was -$146.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$24.00K 10-Q · filed 2026-08-07 | -$52.00K 10-Q · filed 2026-08-07 | $5.00K derived: sum of 3 quarters · filed 2026-08-07 | -$6.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | -$28.00K 10-Q · filed 2026-05-08 | $29.00K derived: sum of 2 quarters · filed 2026-05-08 | $18.00K derived: sum of 3 quarters · filed 2026-05-08 | -$10.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $46.00K derived: sum of 2 quarters · filed 2026-03-25 | $18.00K derived: sum of 3 quarters · filed 2026-08-07 | -$6.00K 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | -$11.00K 10-Q · filed 2025-11-12 | -$39.00K derived: sum of 2 quarters · filed 2026-08-07 | -$63.00K 10-Q · filed 2025-11-12 | -$96.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | -$28.00K 10-Q · filed 2026-08-07 | -$52.00K 10-Q · filed 2026-08-07 | -$85.00K derived: sum of 3 quarters · filed 2026-08-07 | -$221.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | -$24.00K 10-Q · filed 2026-05-08 | -$57.00K derived: sum of 2 quarters · filed 2026-05-08 | -$193.00K derived: sum of 3 quarters · filed 2026-05-08 | -$210.00K derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | -$33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$169.00K derived: sum of 2 quarters · filed 2026-03-25 | -$186.00K derived: sum of 3 quarters · filed 2026-03-25 | -$223.00K 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | -$136.00K 10-Q · filed 2025-11-12 | -$153.00K derived: sum of 2 quarters · filed 2025-11-12 | -$190.00K 10-Q · filed 2025-11-12 | -$160.00K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | -$17.00K 10-Q · filed 2025-08-12 | -$52.00K 10-Q · filed 2025-08-12 | -$24.00K derived: sum of 3 quarters · filed 2025-08-12 | -$59.00K derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$36.00K 10-Q · filed 2025-05-13 | -$7.00K derived: sum of 2 quarters · filed 2025-05-13 | -$42.00K derived: sum of 3 quarters · filed 2025-05-13 | -$72.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | -$6.00K derived: sum of 2 quarters · filed 2025-03-25 | -$36.00K derived: sum of 3 quarters · filed 2025-03-25 | -$70.00K 10-K · filed 2025-03-25 | ||||
| 2023-09-30 | -$35.00K 10-Q · filed 2024-11-12 | -$65.00K derived: sum of 2 quarters · filed 2024-11-12 | -$99.00K 10-Q · filed 2024-11-12 | -$121.00K derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$30.00K 10-Q · filed 2024-08-12 | -$63.00K 10-Q · filed 2024-08-12 | -$86.00K derived: sum of 3 quarters · filed 2024-08-12 | -$86.00K derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | -$33.00K 10-Q · filed 2024-05-13 | -$56.00K derived: sum of 2 quarters · filed 2024-05-13 | -$56.00K derived: sum of 3 quarters · filed 2024-05-13 | -$144.00K derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$23.00K derived: sum of 2 quarters · filed 2024-04-01 | -$111.00K derived: sum of 3 quarters · filed 2024-04-01 | -$146.00K 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | $194.00K 10-Q · filed 2022-11-07 | -$88.00K derived: sum of 2 quarters · filed 2023-11-13 | -$123.00K 10-Q · filed 2023-11-13 | $84.00K 10-Q · filed 2022-11-07 | -$138.00K derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | -$88.00K 10-Q · filed 2023-08-14 | -$77.00K 10-Q · filed 2022-08-08 | -$122.00K 10-Q · filed 2023-08-14 | -$109.00K 10-Q · filed 2022-08-08 | -$138.00K derived: sum of 3 quarters · filed 2023-08-14 | -$177.00K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$40.00K 10-Q · filed 2023-05-15 | -$39.00K 10-Q · filed 2022-05-09 | -$50.00K derived: sum of 2 quarters · filed 2023-05-15 | -$89.00K derived: sum of 3 quarters · filed 2023-05-15 | -$124.00K derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$49.00K derived: sum of 2 quarters · filed 2023-03-22 | -$84.00K derived: sum of 3 quarters · filed 2023-03-22 | -$91.00K 10-K · filed 2023-03-22 | -$85.00K 10-K · filed 2022-02-28 | |||
| 2021-09-30 | -$39.00K 10-Q · filed 2022-11-07 | -$38.55K 10-Q · filed 2021-11-15 | -$74.00K derived: sum of 2 quarters · filed 2022-11-07 | -$81.00K 10-Q · filed 2022-11-07 | -$81.37K 10-Q · filed 2021-11-15 | -$67.00K derived: sum of 4 quarters · filed 2022-11-07 | ||
| 2021-06-30 | -$35.00K 10-Q · filed 2022-08-08 | -$35.48K 10-Q · filed 2021-08-13 | -$43.00K 10-Q · filed 2022-08-08 | -$42.82K 10-Q · filed 2021-08-13 | -$28.00K derived: sum of 3 quarters · filed 2022-08-08 | -$10.25K derived: sum of 4 quarters · filed 2022-08-08 | ||
| 2021-03-31 | -$7.00K 10-Q · filed 2022-05-09 | -$7.34K 10-Q · filed 2021-05-14 | $7.00K derived: sum of 2 quarters · filed 2022-05-09 | $24.75K derived: sum of 3 quarters · filed 2022-05-09 | $54.41K derived: sum of 4 quarters · filed 2022-05-09 | |||
| 2020-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $31.75K derived: sum of 2 quarters · filed 2022-02-28 | $61.41K derived: sum of 3 quarters · filed 2022-02-28 | $51.00K 10-K · filed 2022-02-28 | $50.80K 10-K · filed 2021-03-31 | |||
| 2020-09-30 | $17.75K 10-Q · filed 2021-11-15 | $47.41K derived: sum of 2 quarters · filed 2021-11-15 | $37.00K 10-Q · filed 2021-11-15 | $35.80K derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $29.66K 10-Q · filed 2021-08-13 | $19.25K 10-Q · filed 2021-08-13 | $18.06K derived: sum of 3 quarters · filed 2021-08-13 | $30.34K derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | -$10.41K 10-Q · filed 2021-05-14 | -$11.61K derived: sum of 2 quarters · filed 2021-05-14 | $675.00 derived: sum of 3 quarters · filed 2021-05-14 | $24.21K derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | -$1.20K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $11.09K derived: sum of 2 quarters · filed 2021-03-31 | $34.63K derived: sum of 3 quarters · filed 2021-03-31 | $25.65K 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $12.28K 10-Q · filed 2020-11-13 | $35.82K derived: sum of 2 quarters · filed 2020-11-13 | $26.85K 10-Q · filed 2020-11-13 | $55.90K derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $23.54K 10-Q · filed 2020-08-13 | $14.56K 10-Q · filed 2020-08-13 | $43.62K derived: sum of 3 quarters · filed 2020-08-13 | $43.72K derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | -$8.98K 10-Q · filed 2020-05-13 | $20.08K derived: sum of 2 quarters · filed 2020-05-13 | $20.18K derived: sum of 3 quarters · filed 2020-05-13 | $20.26K derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | $29.06K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $29.16K derived: sum of 2 quarters · filed 2020-03-26 | $29.24K derived: sum of 3 quarters · filed 2020-03-26 | $29.30K 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | $104.00 10-Q · filed 2019-11-13 | $183.00 derived: sum of 2 quarters · filed 2019-11-13 | $242.00 10-Q · filed 2019-11-13 | |||||
| 2018-06-30 | $79.00 10-Q · filed 2019-08-13 | $138.00 10-Q · filed 2019-08-13 | ||||||
| 2018-03-31 | $59.00 10-Q · filed 2019-05-13 | |||||||
| 2017-12-31 | $154.00 10-K · filed 2019-03-28 | |||||||
| 2015-09-30 | $69.34K 10-Q · filed 2015-11-12 | $117.96K derived: sum of 2 quarters · filed 2015-11-12 | $66.55K 10-Q · filed 2015-11-12 | |||||
| 2015-06-30 | $48.62K 10-Q · filed 2015-08-06 | -$2.80K 10-Q · filed 2015-08-06 | ||||||
| 2014-09-30 | -$140.00 10-Q · filed 2015-11-12 | -$1.58K derived: sum of 2 quarters · filed 2015-11-12 | -$2.19K 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | -$1.44K 10-Q · filed 2015-08-06 | -$2.05K 10-Q · filed 2015-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |